Stephen J. Tulipano's most recent trade in Stoke Therapeutics Inc was a trade of 60,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 27, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Stephen J. Tulipano | Former CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | Former CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 13,100 | 24,862 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 13,100 | 39,300 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 15 Mar 2024 | 4,116 | 20,746 (0%) | 0% | 6.1 | 25,102 | Common Stock |
| Stoke Therapeutics Inc | Tulipano J. Stephen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2023 | 107,400 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2023 | 65,600 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Tulipano Stephen J. | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 60,773 | 60,773 | - | - | Restricted Stock Unit (RSU) | |
| Stoke Therapeutics Inc | Tulipano J. Stephen | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2023 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 78,600 | 78,600 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 52,400 | 52,400 | - | - | Restricted Stock Unit (RSU) | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.48 per share. | 02 Jun 2022 | 11,160 | 11,762 (0%) | 0% | 4.5 | 49,997 | Common Stock |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 11,160 | 168,837 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Stephen J. Tulipano | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 107,400 | 107,400 | - | - | Employee Stock Option (Right to Buy) |